Samil Pharm (000520)

Seoul

Currency in KRW

9,100

-290(-3.09%)

Closed·02:29:59

Fair Value

Unlock Value

Day's Range

8,990

9,390

52 wk Range

8,560

13,370

000520 Income Statement

Assess the Samil Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 000520 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

134,246.78

179,676.11

196,345.81

219,699.59

210,253.47

Total Revenues Growth

aa.aa

+9.14%

+33.84%

+9.28%

+11.89%

-4.3%

Cost Of Revenues

aa.aa

85,258.53

112,190.59

122,275.01

138,785.4

133,135

Gross Profit

aa.aa

48,988.24

67,485.52

74,070.79

80,914.18

77,118.48

Gross Profit Growth

aa.aa

-0.09%

+37.76%

+9.76%

+9.24%

-4.69%

Gross Profit Margin %

aa.aa

36.49%

37.56%

37.72%

36.83%

36.68%

Other Operating Expenses, Total

aa.aa

48,588.5

63,468.94

67,610.77

80,866.07

101,056.7

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+14.34%	+30.63%	+6.53%	+19.61%	+24.97%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,971.49	2,907.13	5,600.9	6,513.16	8,462.92
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	43,763.4	58,519.05	59,962.03	70,303.59	82,619.32
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	623.15	637.98	516.12	651.37	729.71

Operating Income

aa.aa

399.74

4,016.58

6,460.03

48.11

-23,938.22

Operating Income Growth

aa.aa

-93.89%

+904.8%

+60.83%

-99.26%

-49,853.41%

EBIT Margin %

aa.aa

0.3%

2.24%

3.29%

0.02%

-11.39%

Net Interest Expenses

aa.aa

-6,072.49

-4,192.86

-3,509.83

-4,994.57

-8,720.88

Net Interest Expenses Growth

aa.aa

-13.69%

+30.95%

+16.29%

-42.3%

-74.61%

Interest Expense, Total

aa.aa

-6,202.48

-4,262.89

-3,544.55

-5,057.42

-8,772.05

Interest And Investment Income

aa.aa

129.99

70.02

34.72

62.84

51.17

Other Non Operating Expenses, Total

aa.aa

545.55

900.67

-2,643.7

1,360.89

-1,316.76

EBT, Excl. Unusual Items

aa.aa

-5,127.2

724.39

306.5

-3,585.57

-33,975.87

Gain (Loss) On Sale Of Assets

aa.aa

365.84

340.82

1,702.29

-27.07

1.14

Other Unusual Items, Total

aa.aa

-2,954.37

EBT, Incl. Unusual Items

aa.aa

-4,761.36

1,058.1

1,423.78

-3,612.64

-37,158.44

EBT, Incl. Unusual Items Growth

aa.aa

-497.42%

+122.22%

+34.56%

-353.74%

-928.57%

EBT, Incl. Unusual Items Margin

aa.aa

-3.55%

0.59%

0.73%

-1.64%

-17.67%

Income Tax Expense

aa.aa

585.31

1,086.38

-239.76

2,016.16

-2,494.74

Net Income to Company

aa.aa

-5,346.66

-28.29

1,663.54

-5,628.8

-34,663.7

Minority Interest

aa.aa

Net Income

aa.aa

-5,346.66

-28.29

1,663.54

-5,628.8

-34,663.7

Net Income Growth

aa.aa

-498.84%

+99.47%

+5,981.02%

-438.36%

-515.83%

Net Income Margin %

aa.aa

-3.98%

-0.02%

0.85%

-2.56%

-16.49%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-5,346.66

-28.29

1,663.54

-5,628.8

-34,663.7

Basic EPS - Continuing Operations

aa.aa

-386.63

-2.03

116.16

-313

-1,632.8

Basic EPS - Continuing Operations Growth

aa.aa

-487.8%

+99.48%

+5,825.31%

-369.46%

-421.66%

Diluted EPS - Continuing Operations

aa.aa

-386.63

-2.03

115

-313

-1,633

Diluted EPS - Continuing Operations Growth

aa.aa

-487.8%

+99.48%

+5,768.3%

-372.17%

-421.73%

Basic Weighted Average Shares Outstanding

aa.aa

13.83

13.94

14.32

17.98

21.23

Diluted Weighted Average Shares Outstanding

aa.aa

13.83

13.94

14.47

17.98

21.23

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

5,111.64

9,005.52

11,828

7,310.92

-14,741.21

EBITDA Growth

aa.aa

-52.4%

+76.18%

+31.34%

-38.19%

-301.63%

EBITDA Margin %

aa.aa

3.81%

5.01%

6.02%

3.33%

-7.01%

EBIT

aa.aa

399.74

4,016.58

6,460.03

48.11

-23,938.22

* In Millions of KRW (except for per share items)

FAQ

What was Samil Pharm’s revenue at year end?

At the end of the last reported fiscal year, Samil Pharm (000520) recorded total revenue of 210,253 million KRW.

How much revenue did Samil Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Samil Pharm posted revenue of 53,004 million KRW.

What was Samil Pharm’s net income for the year?

For the full year, Samil Pharm reported net income of -34,664 million KRW.

How much net income did Samil Pharm post in the last quarter?

In the most recent quarter, Samil Pharm (000520) posted net income of -11,160 million KRW.

What was Samil Pharm’s gross profit for the year?

Gross profit for the year was reported at 77,118 million KRW.

How much gross profit did Samil Pharm generate last quarter?

Samil Pharm recorded gross profit of 19,448 million KRW in its latest quarterly report.

What was Samil Pharm’s annual operating income?

For the full year, Samil Pharm (000520) reported operating income of -23,938 million KRW.

What was Samil Pharm’s operating income last quarter?

Quarterly operating income was -10,267 million KRW.

What was Samil Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -7,968 million KRW.

What was the quarter-over-quarter change in EBITDA for Samil Pharm?

EBITDA changed by -318% million KRW compared to the last quarter.

What is Samil Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Samil Pharm (000520) is 37% million KRW.

What is Samil Pharm’s most recent net income margin?

Net income margin based on recent financials is -21% million KRW.

What is Samil Pharm’s most recent EBIT margin?

Samil Pharm reported an EBIT margin of -19% million KRW based on current figures.

How did Samil Pharm’s revenue change compared to the previous quarter?

Revenue changed by 4% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Samil Pharm?

In the latest quarter, gross profit changed by 5% million KRW from the previous quarter.

S&P/TSX

33,318.39

-265.95

-0.79%

S&P/TSX 60

1,943.80

-15.19

-0.78%

US 30

48,652.40

-483.8

-0.98%

US 500

7,110.70

-28.1

-0.39%

S&P 500 VIX

18.78

+0.95

+5.33%

DAX

23,954.56

-63.70

-0.27%

Dollar Index

98.84

+0.360

+0.36%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	31.97	+1.91%	16.45M
ARC Resources	31.95	+1.30%	12.76M
Enbridge	73.01	+0.55%	8.11M
Manulife Financial	52.26	-1.02%	7.97M
TC Energy	87.56	+1.59%	7.06M
Toronto Dominion Bank	142.93	-0.84%	5.46M
RBC	239.99	-1.30%	2.68M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Navco Pharmaceuticals	0.010	+100.00%	5.00K
Spod Lithium	0.01	+100.00%	2.64K
Montfort Capital	0.0100	+100.00%	1.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Vice Health Wellness	0.005	-50.00%	2.22M
Albert Labs International	0.005	-50.00%	1.00K
New Frontier Ventures	0.015	-50.00%	4.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	515.17	+4.45%	560.67K
Whitecap Resources	16.02	+2.30%	8.15M
Canadian Natural	64.63	+1.88%	6.04M
Air Canada	18.01	-0.17%	2.66M
Cenovus Energy Inc	39.37	+4.85%	7.93M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaa Aa Aaa A	5.15	+65.58%	8.53
Aa Aaaa	5.88	+56.25%	9.19
Aa Aa Aaaaaaaa	89.78	+53.66%	137.96
Aaaaa Aaa	10.49	+43.00%	15.00
Aaa Aaaaaa	10.84	+42.37%	15.43
Aaaaaaaaaaaaa	23.15	+41.90%	32.85
Aaaaaaaaa	3.63	+40.60%	5.10

Name	Last	Upside	Fair Value
Aaaa Aa Aaa A	5.15	+65.58%	8.53
Aa Aaaa	5.88	+56.25%	9.19
Aa Aa Aaaaaaaa	89.78	+53.66%	137.96
Aaaaa Aaa	10.49	+43.00%	15.00
Aaa Aaaaaa	10.84	+42.37%	15.43
Aaaaaaaaaaaaa	23.15	+41.90%	32.85
Aaaaaaaaa	3.63	+40.60%	5.10

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Samil Pharm (000520)

000520 Income Statement

FAQ

What was Samil Pharm’s revenue at year end?

How much revenue did Samil Pharm report in the most recent quarter?

What was Samil Pharm’s net income for the year?

How much net income did Samil Pharm post in the last quarter?

What was Samil Pharm’s gross profit for the year?

How much gross profit did Samil Pharm generate last quarter?

What was Samil Pharm’s annual operating income?

What was Samil Pharm’s operating income last quarter?

What was Samil Pharm’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Samil Pharm?

What is Samil Pharm’s most recent gross profit margin?

What is Samil Pharm’s most recent net income margin?

What is Samil Pharm’s most recent EBIT margin?

How did Samil Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Samil Pharm?

Trending Stocks